{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:02:38Z","timestamp":1789974158411,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["chestpulmonary.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST Pulmonary"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chpulm.2026.100240","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:24:09Z","timestamp":1771658649000},"page":"100240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medium-Dose Compared With High-Dose Inhaled Corticosteroids in Combination Triple Inhaler Therapy for Asthma"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0008-5652","authenticated-orcid":false,"given":"Samantha","family":"Warhurst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Sayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kulathinal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0051-9107","authenticated-orcid":false,"given":"Mark","family":"Weatherall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chpulm.2026.100240_bib2","first-page":"16","article-title":"Clinical dose-response relationship of fluticasone propionate in adults with asthma","volume":"59","author":"Masoli","year":"2004","journal-title":"Thorax"},{"issue":"7307","key":"10.1016\/j.chpulm.2026.100240_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.323.7307.253","article-title":"Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis","volume":"323","author":"Holt","year":"2001","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.chpulm.2026.100240_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","article-title":"Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology","volume":"199","author":"Beasley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chpulm.2026.100240_bib5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.chest.2025.08.014","article-title":"The dose-response of inhaled corticosteroids in combination ICS\/LABA maintenance therapy for asthma: a systematic review and meta-analysis","volume":"168","author":"Noble","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.chpulm.2026.100240_bib6","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.chpulm.2026.100240_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106021","article-title":"Fixed-dose combination of indacaterol\/glycopyrronium\/mometasone furoate once-daily versus salmeterol\/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: a randomised, phase IIIb, non-inferiority study (ARGON)","volume":"170","author":"Gessner","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.chpulm.2026.100240_bib8","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.chpulm.2026.100240_bib9","author":"Sch\u00fcnemann"},{"issue":"12","key":"10.1016\/j.chpulm.2026.100240_bib11","first-page":"CD013799","article-title":"Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis","author":"Oba","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.chpulm.2026.100240_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102068","article-title":"Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate\/indacaterol and mometasone furoate\/ indacaterol\/glycopyrronium in patients with asthma","volume":"70","author":"Buhl","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.chpulm.2026.100240_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jclinepi.2020.11.003","article-title":"Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane Reviews","volume":"133","author":"Thomas","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100240_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.chpulm.2026.100240_bib16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone\u2013indacaterol\u2013glycopyrronium versus mometasone\u2013indacaterol or twice-daily fluticasone\u2013salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100240_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An Official American Thoracic Society\/European Respiratory Society Statement: asthma control and exacerbations","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100240_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1399-3003.1999.14a06.x","article-title":"What are minimal important changes for asthma measures in a clinical trial?","volume":"14","author":"Santanello","year":"1999","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100240_bib19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chpulm.2026.100240_bib20","first-page":"1149","article-title":"Inhaled corticosteroid-containing treatment escalation and outcomes for patients with asthma in a US health care organization","volume":"23","author":"Bengtson","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.chpulm.2026.100240_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaip.2022.10.040","article-title":"Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study","volume":"11","author":"Pavord","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100240_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04233-2020","article-title":"Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies","volume":"58","author":"Rogliani","year":"2021","journal-title":"Eur Respir J"},{"issue":"10210","key":"10.1016\/j.chpulm.2026.100240_bib23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100240_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/thx.2006.066837","article-title":"External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?","volume":"62","author":"Travers","year":"2007","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100240_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1164\/rccm.202308-1436OC","article-title":"Prevalence, diagnostic utility and associated characteristics of bronchodilator responsiveness","volume":"209","author":"Beasley","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chpulm.2026.100240_bib26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.chpulm.2026.100240_bib28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2010.06.019","article-title":"Inhaled corticosteroids and the risks of diabetes onset and progression","volume":"123","author":"Suissa","year":"2010","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.chpulm.2026.100240_bib29","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2222.2008.03029.x","article-title":"Dose\u2013response relationship for risk of non-vertebral fracture with inhaled corticosteroids","volume":"38","author":"Weatherall","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.chpulm.2026.100240_bib30","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaip.2025.01.023","article-title":"Use of high-dose inhaled corticosteroids and risk of corticosteroid-related adverse events in asthma findings from the NORDSTAR cohort","volume":"13","author":"von B\u00fclow","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100240_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaip.2023.09.034","article-title":"Comorbidity burden in severe and nonsevere asthma: a nationwide observational study (FINASTHMA)","volume":"12","author":"Kankaanranta","year":"2024","journal-title":"J Allergy Clin Immunol Practice"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100240_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41533-024-00402-w","article-title":"Burden of illness among patients with asthma prescribed inhaled corticosteroids\/long-acting \u03b22-agonists","volume":"35","author":"Zhang","year":"2025","journal-title":"Npj Prim Care Respir Med"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100240_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00408-025-00796-5","article-title":"Supratherapeutic inhaled corticosteroid use in patients initiating on biologic therapies for severe asthma: a nationwide cohort study","volume":"203","author":"Hjortdahl","year":"2025","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100240_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00625-2020","article-title":"SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis","volume":"56","author":"Rogliani","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chpulm.2026.100240_bib35","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting \u03b2-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100240_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0615","article-title":"Evaluation of budesonide-formoterol for maintenance and reliever therapy among patients with poorly controlled asthma: a systematic review and meta-analysis","volume":"5","author":"Beasley","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"22","key":"10.1016\/j.chpulm.2026.100240_bib37","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa2203163","article-title":"Albuterol\u2013budesonide fixed-dose combination rescue inhaler for asthma","volume":"386","author":"Papi","year":"2022","journal-title":"N Engl J Med"}],"container-title":["CHEST Pulmonary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789226000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789226000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:25:18Z","timestamp":1789971918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949789226000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2949789226000073"],"URL":"https:\/\/doi.org\/10.1016\/j.chpulm.2026.100240","relation":{},"ISSN":["2949-7892"],"issn-type":[{"value":"2949-7892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medium-Dose Compared With High-Dose Inhaled Corticosteroids in Combination Triple Inhaler Therapy for Asthma","name":"articletitle","label":"Article Title"},{"value":"CHEST Pulmonary","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chpulm.2026.100240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100240"}}